Key Research Features: 50mg per capsule, 60-count bottle Investigational compound targeting NNMT enzyme activity Supports studies on metabolism, energy, and fat oxidation High-purity formula for accurate, reproducible results Ideal for metabolic and cellular bioenergetics research 5-Amino-1MQ 50mg 60 Capsules delivers research-grade consistency for scientists studying metabolic modulation, energy efficiency, and advanced biochemical pathways.

Selective NNMT inhibitor substrate site-targeting mechanism with IC50 of 1.2 M in reference assay conditions Selectivity over related methyltransferases does not significantly affect other enzymes in the NAD salvage pathway at research concentrations Reduces intracellular 1-methylnicotinamide (1-MNA) formation in cell-based assay models Studied in adipocyte, liver, and skeletal muscle cell-based research models examining NNMT-dependent methylation pathway dynamics Referenced at Sigma-Aldrich (SML2832) and in peer-reviewed literature on NNMT enzyme biology Membrane-permeable quaternary quinolinium scaffold studied for intracellular NNMT target engagement in cell-based models Batch and lot identifiers on all labeling for full laboratory documentation compliance Research Background 5-Amino-1MQ was first characterized as a selective NNMT inhibitor in published research literature in 2018
Switching up where you inject helps avoid soreness and ensures the shot works well
Relying on the precise NNMT inhibition mechanism and the advantages of oral solid preparations, they have become distinctive research-oriented formulations in the field of cellular energy and metabolic management.The capsule formulation features high stability, precise dosage, and convenient administration
Knowing how long reconstituted peptides last in the fridge , understanding shelf life considerations , and being able to identify whether the color of your solution indicates a problem all help users maintain product integrity throughout their protocol